Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition

Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer

(2018) Yanying Zhao et al.   Cancer Biomarkers

Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer

(2018) Alicia C. McDonald et al.   PROSTATE

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

(2017) James A. Kuzman et al.   BMC Urology

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer

(2017) Marilesia Ferreira de Souza et al.   PLoS One

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer

(2015) Silvia Antolín et al.   BMC CANCER

The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer

(2015) Xiaoying Zhou et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer

(2015) Darina Kachakova et al.   DNA AND CELL BIOLOGY

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer

(2015) Gloria Bertoli et al.   Theranostics

A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group

(2015) Brian Kelly et al.   Journal of Clinical Medicine

MicroARN circulantes en sangre de pacientes con cáncer de próstata

(2014) V. Medina-Villaamil et al.   Actas Urologicas Espanolas

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Circulating microRNAs as potential new biomarkers for prostate cancer

(2013) A Sita-Lumsden et al.   BRITISH JOURNAL OF CANCER

Profiling of circulating microRNAs for prostate cancer biomarker discovery

(2013) Christa Haldrup et al.   Drug Delivery and Translational Research

Exploiting sparseness in de novo genome assembly

(2012) Chengxi Ye et al.   BMC BIOINFORMATICS

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

(2012) Martina Redova et al.   Journal of Translational Medicine

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

(2011) Jason C. Gonzales et al.   Clinical Genitourinary Cancer

Haemolysis during Sample Preparation Alters microRNA Content of Plasma

(2011) Michaela B. Kirschner et al.   PLoS One

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

(2011) Fulya Yaman Agaoglu et al.   TUMOR BIOLOGY

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

Towards the definition of prostate cancer-related microRNAs: where are we now?

(2009) Paolo Gandellini et al.   TRENDS IN MOLECULAR MEDICINE

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

(2008) S. Ambs et al.   CANCER RESEARCH

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA